Table 2.
Prevalence of individual stroke symptoms among REGARDS study participants.
| Individual stroke symptoms | ||||||
|---|---|---|---|---|---|---|
| Sub-group | Unilateral numbness (n=2,243) | Unilateral painless weakness (n=1,543) | Painless loss of vision (n=1,190) | Loss of ability to communicate (n=947) | Loss of one half of vision (n=794) | Loss of ability to understand (n=707) |
| Overall | 8.4% | 5.8% | 4.4% | 3.5% | 3.0% | 2.6% |
| Age, years | ||||||
| <55 | 11.5% | 7.9% | 4.8% | 4.4% | 3.0% | 3.0% |
| 55 – 64 | 9.0% | 6.3% | 4.3% | 3.5% | 2.7% | 2.3% |
| 65 – 74 | 7.3% | 4.7% | 4.3% | 3.0% | 3.1% | 2.2% |
| ≥75 | 6.3% | 4.8% | 4.8% | 4.1% | 3.3% | 3.9% |
| Race | ||||||
| Blacks | 11.6% | 8.1% | 4.8% | 4.2% | 3.3% | 3.5% |
| Whites | 6.1% | 4.2% | 4.2% | 3.1% | 2.7% | 2.0% |
| Sex | ||||||
| Women | 9.1% | 6.2% | 4.5% | 4.1% | 3.1% | 2.7% |
| Men | 7.5% | 5.2% | 4.3% | 2.9% | 2.8% | 2.6% |
| Current smoker | ||||||
| Yes | 12.6% | 9.0% | 5.9% | 4.9% | 3.6% | 3.7% |
| No | 7.7% | 5.2% | 4.2% | 3.3% | 2.9% | 2.5% |
| Hypertension | ||||||
| Yes | 9.5% | 6.8% | 4.9% | 3.9% | 3.3% | 3.1% |
| No | 6.9% | 4.3% | 3.9% | 3.0% | 2.6% | 2.1% |
| Diabetes | ||||||
| Yes | 11.3% | 8.2% | 6.4% | 4.5% | 4.5% | 4.1% |
| No | 7.6% | 5.1% | 3.9% | 3.3% | 2.6% | 2.3% |
Shaded areas indicate that the prevalence is statistically significantly (p<0.05) different in the subgroup for individual stroke symptoms.